Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas

Michael McDermott

Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas

Miami Neuroscience Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	23
State	Published - Nov 2 2021

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{93bcea3af9a2436ea30503725f84ca4b,

title = "Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas",

author = "Michael McDermott",

note = "Neuro-Oncology (2021) 23(11):1872-1884",

year = "2021",

month = nov,

day = "2",

language = "American English",

volume = "23",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas

AU - McDermott, Michael

N1 - Neuro-Oncology (2021) 23(11):1872-1884

PY - 2021/11/2

Y1 - 2021/11/2

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4292

M3 - Article

VL - 23

JO - Neuro-oncology

JF - Neuro-oncology

ER -

Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas

Access to Document

Other files and links

Cite this